{"public_id":"cl_05cf87db855e5162323de54d3f2eca99","status":"active","superseded_by_public_id":null,"corpus_id":53037961,"text":"Median nerve stimulation-induced antinociception is blocked by OX1R antagonism, CB1R antagonism, and inhibition of 2-arachidonoylglycerol synthesis, but not by opioid receptor antagonists.","confidence":0.99,"paper":{"corpus_id":53037961,"title":"Median nerve stimulation induces analgesia via orexin-initiated endocannabinoid disinhibition in the periaqueductal gray","url":"https://sah.borca.ai/papers/53037961"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.99,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_2a5f4bafc40386d7b71000403ac8fdcd","name":"2-arachidonoylglycerol","description":"An endocannabinoid lipid mediator referred to as 2-AG.","types":["endocannabinoid"],"url":"https://sah.borca.ai/concepts/co_2a5f4bafc40386d7b71000403ac8fdcd"},{"public_id":"co_65655e6ae57a2fd588b11ba66dd8ec1a","name":"cannabinoid 1 receptor","description":"A cannabinoid receptor referred to as CB1R in the study.","types":["receptor"],"url":"https://sah.borca.ai/concepts/co_65655e6ae57a2fd588b11ba66dd8ec1a"},{"public_id":"co_b46c4c400540f919eb26f00f73bb3704","name":"orexin 1 receptor","description":"A receptor for orexin signaling referred to as OX1R in the study.","types":["receptor"],"url":"https://sah.borca.ai/concepts/co_b46c4c400540f919eb26f00f73bb3704"},{"public_id":"co_e642ff115fe8b4cadc443f01b417cd80","name":"opioid receptor antagonists","description":"Drugs that block opioid receptors and were used to test opioid dependence of the analgesic effect.","types":["pharmacological agent"],"url":"https://sah.borca.ai/concepts/co_e642ff115fe8b4cadc443f01b417cd80"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_05cf87db855e5162323de54d3f2eca99"}